الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 91 |  |  |
| | | from | 91 | | |
Abstract
Type 2 diabetes is a common chronic disease in the general population. Approximately 7-30% of diabetes cases remain undiagnosed. In addition, there are a significant number of individuals with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), who are at risk of developing diabetes if no actions are undertaken. Finnish Diabetes Risk Score (FINDRISC) is the most commonly used risk score in detecting undiagnosed diabetes. In this study we tried to evaluate the FINDRISC for estimating the probability of a person to develop type2 DM within the next 10 years. Use of such a scoring system is of great significance and could prove to be cost effective, reliable, valuable and easy to use screening tool for detecting risk of diabetes. In this study we use FINDRISC questionnaire in survey of 500 subjects from Beni-Suef University hospital outpatient clinic who are unknown diabetic, not on steroids or hormonal therapy and not have renal impaired. They were distributed as 49.6% males and 50.4% females. Subjects’ age was ranged from 20 to 80 years old with an average of 48.48 years. Female patients who had ever been found to have high blood glucose (e.g. in a health examination, during an illness, during pregnancy) were significantly higher than males (36.5% vs. 8.9%) in females and males respectively with a significant p-value (0.001). Other studied risk factors (BMI, Waist circumference, physical activity, Eating Vegetables & Fruits and Family History) showed no statistically significant differences between males and females; (p-values>0.05).We found that more than half (52.8%) of the studied population had low to moderate risk, 27.2% had high risk, 20% had very high risk to develop type 2 DM in the next 10 years with no statistically significant difference between males and females regarding the total FINDRISC score. Total FINDRISC score was moderately positive correlated with patient’s age in years and with patient’s BMI and was strongly positive correlated with blood glucose tests (FBS, 2hPP and Hb A1C). Total FINDRISC score was slightly positive correlated with blood urea level. No detected correlation between Total FINDRISC score and Serum Creatinine of the studied cases.
from the present study we concluded that FINDRISC can be a suitable, reliable, valuable and easy tool to predict type 2 DM in the next 10 years.